Suppr超能文献

轻度哮喘成人急性哮喘加重的危险因素

Risk Factors for Acute Asthma Exacerbations in Adults With Mild Asthma.

作者信息

Chen Wansu, Puttock Eric J, Schatz Michael, Crawford William, Vollmer William M, Xie Fagen, Xu Stanley, Lustigova Eva, Zeiger Robert S

机构信息

Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, Calif.

Department of Research and Evaluation, Kaiser Permanente Southern California, Pasadena, Calif.

出版信息

J Allergy Clin Immunol Pract. 2024 Oct;12(10):2705-2716.e6. doi: 10.1016/j.jaip.2024.05.034. Epub 2024 May 29.

Abstract

BACKGROUND

Although individuals with mild asthma account for 30% to 40% of acute asthma exacerbations (AAEs), relatively little attention has been paid to risk factors for AAEs in this population.

OBJECTIVE

To identify risk factors associated with AAEs in patients with mild asthma.

METHODS

This was a retrospective cohort study. We used administrative data from a large managed care organization to identify 199,010 adults aged 18 to 85 years who met study criteria for mild asthma between 2013 and 2018. An asthma-coded qualifying visit (index visit) was identified for each patient. We then used information at the index visit or from the year before the index visit to measure potential risk factors for AAEs in the subsequent year. An AAE was defined as either an asthma-coded hospitalization or emergency department visit, or an asthma-related systemic corticosteroid administration (intramuscular or intravenous) or oral corticosteroid dispensing. Poisson regression models with robust SEs were used to estimate the adjusted risk ratios for future AAEs.

RESULTS

In the study cohort, mean age was 44 years and 64% were female; 6.5% had AAEs within 1 year after the index visit. In multivariate models, age, sex, race, ethnicity, smoking status, body mass index, prior acute asthma care, and a variety of comorbidities and other clinical characteristics were significant predictors for future AAE risk.

CONCLUSION

Population-based disease management strategies for asthma should be expanded to include people with mild asthma in addition to those with moderate to severe disease.

摘要

背景

尽管轻度哮喘患者占急性哮喘加重(AAE)的30%至40%,但该人群中AAE的危险因素相对较少受到关注。

目的

确定轻度哮喘患者中与AAE相关的危险因素。

方法

这是一项回顾性队列研究。我们使用了一个大型管理式医疗组织的管理数据,以识别199,010名年龄在18至85岁之间、在2013年至2018年期间符合轻度哮喘研究标准的成年人。为每位患者确定一次哮喘编码的合格就诊(索引就诊)。然后,我们使用索引就诊时或索引就诊前一年的信息来衡量随后一年中AAE的潜在危险因素。AAE被定义为哮喘编码的住院或急诊科就诊,或哮喘相关的全身皮质类固醇给药(肌肉注射或静脉注射)或口服皮质类固醇配药。使用具有稳健标准误的泊松回归模型来估计未来AAE的调整风险比。

结果

在研究队列中,平均年龄为44岁,64%为女性;6.5%在索引就诊后1年内发生AAE。在多变量模型中,年龄、性别、种族、民族、吸烟状况、体重指数、既往急性哮喘治疗以及各种合并症和其他临床特征是未来AAE风险的重要预测因素。

结论

基于人群的哮喘疾病管理策略应扩大到包括轻度哮喘患者以及中重度疾病患者。

相似文献

1
Risk Factors for Acute Asthma Exacerbations in Adults With Mild Asthma.
J Allergy Clin Immunol Pract. 2024 Oct;12(10):2705-2716.e6. doi: 10.1016/j.jaip.2024.05.034. Epub 2024 May 29.
4
High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma.
J Allergy Clin Immunol Pract. 2014 Nov-Dec;2(6):741-50. doi: 10.1016/j.jaip.2014.06.005. Epub 2014 Aug 29.
5
Real life data on incidence and risk factors of severe asthma exacerbations in children in primary care.
Respir Med. 2016 Oct;119:48-54. doi: 10.1016/j.rmed.2016.08.016. Epub 2016 Aug 23.
6
Burden of Chronic Oral Corticosteroid Use by Adults with Persistent Asthma.
J Allergy Clin Immunol Pract. 2017 Jul-Aug;5(4):1050-1060.e9. doi: 10.1016/j.jaip.2016.12.023. Epub 2017 Feb 10.
8
Combination fixed-dose beta agonist and steroid inhaler as required for adults or children with mild asthma.
Cochrane Database Syst Rev. 2021 May 4;5(5):CD013518. doi: 10.1002/14651858.CD013518.pub2.
9
Intramuscular versus oral corticosteroids to reduce relapses following discharge from the emergency department for acute asthma.
Cochrane Database Syst Rev. 2018 Jun 2;6(6):CD012629. doi: 10.1002/14651858.CD012629.pub2.
10
Severe asthma exacerbations in the United States:: Incidence, characteristics, predictors, and effects of biologic treatments.
Ann Allergy Asthma Immunol. 2021 Nov;127(5):579-587.e1. doi: 10.1016/j.anai.2021.07.010. Epub 2021 Jul 15.

本文引用的文献

1
Research data warehouse: using electronic health records to conduct population-based observational studies.
JAMIA Open. 2023 Jun 21;6(2):ooad039. doi: 10.1093/jamiaopen/ooad039. eCollection 2023 Jul.
2
Type 2 Diabetes Mellitus and Asthma: Pathomechanisms of Their Association and Clinical Implications.
Cureus. 2023 Mar 12;15(3):e36047. doi: 10.7759/cureus.36047. eCollection 2023 Mar.
3
Is mild asthma truly mild? The patients' real-life setting.
Expert Rev Respir Med. 2022 Nov-Dec;16(11-12):1263-1272. doi: 10.1080/17476348.2023.2167714. Epub 2023 Jan 18.
4
Dyslipidemia Is Associated With Worse Asthma Clinical Outcomes: A Prospective Cohort Study.
J Allergy Clin Immunol Pract. 2023 Mar;11(3):863-872.e8. doi: 10.1016/j.jaip.2022.11.037. Epub 2022 Dec 16.
5
The burden of mild asthma: Clinical burden and healthcare resource utilisation in the NOVELTY study.
Respir Med. 2022 Aug-Sep;200:106863. doi: 10.1016/j.rmed.2022.106863. Epub 2022 May 9.
10
The burden of exacerbations in mild asthma: a systematic review.
ERJ Open Res. 2020 Aug 11;6(3). doi: 10.1183/23120541.00359-2019. eCollection 2020 Jul.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验